BRCA gene patent case

Options
leaf
leaf Member Posts: 8,188
A federal judge in New York has ruled that seven patents related to breast cancer gene mutations licensed by Myriad Genetics are invalid.Genome policy expert Robert Cook-Deegan explains what the ruling might mean for patients, genetic testing and biotech research.
http://www.npr.org/templates/story/story.php?storyId=125502332

Comments

Categories